Invention Grant
- Patent Title: Methods and compositions using highly conserved pneumococcal surface proteins
-
Application No.: US15939850Application Date: 2018-03-29
-
Publication No.: US10525119B2Publication Date: 2020-01-07
- Inventor: Richard N. Goldstein
- Applicant: Boston Medical Center Corporation
- Applicant Address: US MA Boston
- Assignee: Boston Medical Center Corporation
- Current Assignee: Boston Medical Center Corporation
- Current Assignee Address: US MA Boston
- Agency: Yankwich & Associates, P.C.
- Agent Leon R. Yankwich, Esq.; Thomas R. Berka, Esq.
- Main IPC: A61K39/09
- IPC: A61K39/09 ; A61P31/04 ; A61K39/00

Abstract:
Cold spot genes of S. pneumoniae are disclosed that encode surface proteins that are universally conserved among known strains and have exceptionally low incidence of allelic variation. Cold spot polypeptides encoded by the genes that are antigenic on the S. pneumoniae cells on which they are expressed are candidates for immunogenic compositions capable of eliciting antibodies able to react with all or nearly all strains of S. pneumoniae, thus providing an improvement over currently available S. pneumoniae vaccines that protect inoculated individuals against a maximum of about 23 of the 94 or so known serotypes of S. pneumonia.
Public/Granted literature
- US20180280493A1 Methods and Compositions Using Highly Conserved Pneumococcal Surface Proteins Public/Granted day:2018-10-04
Information query